Vascular Endothelial Growth Factor Receptor-1
-
Subject Areas on Research
-
A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.
-
Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
-
Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.
-
Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training.
-
Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester.
-
Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study.
-
Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport.
-
Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence.
-
Differential expression of VEGF isoforms in mouse during development and in the adult.
-
Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
-
First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
-
Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids.
-
Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.
-
Glycogen Synthase Kinase 3β Inhibition Improves Myocardial Angiogenesis and Perfusion in a Swine Model of Metabolic Syndrome.
-
Hypoxic Gene Expression of Donor Bronchi Linked to Airway Complications after Lung Transplantation.
-
Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
-
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
-
Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.
-
Metabolism and vascular fatty acid transport.
-
PAX3-FOXO1 fusion gene in rhabdomyosarcoma.
-
Phase I study of every 2- or 3-week dosing of ramucirumab, a human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2 in patients with advanced solid tumors.
-
Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer.
-
Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.
-
Regulation of flt-1 expression during mouse embryogenesis suggests a role in the establishment of vascular endothelium.
-
Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells.
-
Relationship of smoking and fibrosis in patients with chronic hepatitis C.
-
Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study.
-
Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth.
-
The effect of cigarette smoke extract on trophoblast cell viability and migration: the role of adrenomedullin.
-
The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival.
-
Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways.
-
Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt.
-
VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.
-
Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
-
Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades.
-
Keywords of People